LOGIN
Bupivacaine In Pericapsular Nerve Group Block During Hip Fracture Surgery
November 2024
Bupivacaine In Pericapsular Nerve Group Block During Hip Fracture Surgery
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Evaluation of two doses (20 mL and 15 mL) of 0.25% bupivacaine in pericapsular nerve group block for patient positioning for sub-arachnoid block during hip fracture surgery: A single-centre, randomised comparative trial.
Indian J Anaesth . 2024 Apr;68(4):323-328.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Sixty patients aged 40–90 years with hip fractures were randomized to receive either 20 mL (n=30) or 15 mL (n=30) of 0.25% bupivacaine through a pericapsular nerve group (PENG) block before sub-arachnoid block (SAB). The primary outcome was the ease of positioning (EOP) for SAB, graded from unsatisfactory to optimal. Secondary outcomes included verbal analogue scale (VAS) pain scores at rest and d...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.